logo
Select company
Select metric
$ -75.39MConsolidated Income
VS
Market
15
Sector
28
Industry
37
History
89
$ 4.07Close
$ 3.15 - $ 9.35 52-Week Range
Ticker Information

Ticker

FHTX

Company Name

FOGHORN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

FOGHORN THERAPEUTICS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

FHTX - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -75.39M
3/31/2025$ -80.44M
12/31/2024$ -86.62M
9/30/2024$ -91.22M
6/30/2024$ -86.45M
3/31/2024$ -92.95M
12/31/2023$ -98.43M
9/30/2023$ -103.21M
6/30/2023$ -114.63M
3/31/2023$ -112.46M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • FOGHORN THERAPEUTICS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -68.8M.
  • Over the past 5 years, FOGHORN THERAPEUTICS INC's average Cons. Inc. has been $ -95.71M.
  • The median Cons. Inc. for FOGHORN THERAPEUTICS INC during this period was $ -95.69M
  • FOGHORN THERAPEUTICS INC reached its highest Cons. Inc. over the past 5 years at $ -68.8M.
  • The lowest Cons. Inc. recorded by FOGHORN THERAPEUTICS INC in the same timeframe $ -114.63M

FOGHORN THERAPEUTICS INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
OABI : OMNIAB INC $ -63.52MFENC : FENNEC PHARMACEUTICALS INC $ -12.04MVYGR : VOYAGER THERAPEUTICS INC $ -107.93MCAPR : CAPRICOR THERAPEUTICS INC $ -69.98MLCTX : LINEAGE CELL THERAPEUTICS INC $ -40.76MCCCC : C4 THERAPEUTICS INC $ -111.58MALMS : ALUMIS INC $ -227.52MWHWK : WHITEHAWK THERAPEUTICS INC $ -10.42MOCGN : OCUGEN INC $ -56.94MEDIT : EDITAS MEDICINE INC $ -236.86M

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

FHTX - Consolidated Income, Last 5 years

$ -114.63M

Minimum

Jun 30, 2023

$ -68.8M

Maximum

Dec 31, 2020

$ -95.71M

Average

$ -95.69M

Median

Cons. Inc. Benchmark Analysis

The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.01M with a standard deviation of $ 116.51M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.01M
median$ -2.1M
std$ 116.51M